← Back to feedRead original →
VERIFIEDET Stocks·positive
Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?
AI Summary
- ·Zydus Lifesciences shares reached a new 52-week high, increasing by 7%.
- ·The company announced a 9% rise in net profit and over 16% revenue growth for the January-March quarter.
- ·A share buyback program of Rs 1,100 crore was announced.